Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s stock price dropped 4.3% during trading on Friday . The company traded as low as $4.19 and last traded at $4.19. Approximately 3,000 shares traded hands during mid-day trading, an increase of 40% from the average daily volume of 2,150 shares. The stock had previously closed at $4.38.
Mayne Pharma Group Trading Down 4.3 %
The firm’s 50 day moving average price is $3.95 and its two-hundred day moving average price is $3.26.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: International Branded Products, and Portfolio Product Division.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- How to Profit From Growth Investing
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Insider Trades May Not Tell You What You Think
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Manufacturing Stocks Investing
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
